Sunday, 6 December 2020

Protagonist Announces Updated Phase 2 Data Presented at ASH Annual Meeting Supporting Long Term Efficacy of Hepcidin Mimetic PTG-300 in the Treatment of Polycythemia Vera - StreetInsider.com

Protagonist Announces Updated Phase 2 Data Presented at ASH Annual Meeting Supporting Long Term Efficacy of Hepcidin Mimetic PTG-300 in the Treatment of Polycythemia Vera  StreetInsider.com

from "phlebotomist" - Google News https://bit.ly/36LufEC

No comments:

Post a Comment